<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04808440</url>
  </required_header>
  <id_info>
    <org_study_id>APHP201463</org_study_id>
    <nct_id>NCT04808440</nct_id>
  </id_info>
  <brief_title>Intubation Conditions With Atracurium After Three Minutes</brief_title>
  <acronym>CINTROI</acronym>
  <official_title>Evaluation of Intubation Conditions With the Use of Atracurium After a Fixed Three-minute Delay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate intubation conditions with the use of atracurium&#xD;
      after a fixed three-minute delay&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The recommended dose of a non-depolarizing curare to facilitate tracheal intubation is twice&#xD;
      the active dose 95 (the dose that reduces muscle force by 95%). At this dosage, curarization&#xD;
      of the laryngeal adductors allowing relaxation and abduction (opening) of the vocal cords is&#xD;
      considered certain. With atracurium, the dose for intubation is 0.5 mg.kg-1 and the time to&#xD;
      full effect is approximately 3 minutes. With the use of newer hypnotics, there are no data&#xD;
      evaluating the conditions for intubation after a fixed time of 3 minutes as with current&#xD;
      anesthetic practices.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2021</start_date>
  <completion_date type="Anticipated">September 23, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 23, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intubation condition</measure>
    <time_frame>3 minutes after atracurium injection</time_frame>
    <description>The intubating conditions were evaluated on the basis of the consensus conference on Good Clinical Research Practice in Pharmacodynamic Studies of Neuromuscular Blocking Agents. The score used include the following variables: (1) ease of laryngoscopy, (2) vocal cord position, and (3) reaction to the insertion of the endotracheal tube and the cuff inflation (eg, diaphragmatic movement due to patient cough). Each of these variables was rated as (1) excellent, (2) good, or (3) poor. Intubating conditions were scored as excellent if all variables were excellent; the score was good if at least 1 variable was good and the rest were excellent; the conditions were considered poor if any of the variables was rated poor.&#xD;
Evaluation of intubation conditions with the use of atracurium after a fixed three-minute delay</description>
  </primary_outcome>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Obesity Female Patients Require General Anaesthesia With Intubation and Atracurium Curarization</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults, no morbid obesity female patients, without risk factors for difficult tracheal&#xD;
        intubation (ref IOT difficile) scheduled for gynaecologic surgery were prospectively&#xD;
        included in this observational and monocentric study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult female&#xD;
&#xD;
          -  Patient to undergo general anesthesia with intubation for scheduled gynecological&#xD;
             surgery&#xD;
&#xD;
          -  Patient informed about the study and not opposed to it&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with severe and morbid obesity (BMI&gt;35kg/m2)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patients with difficult intubation&#xD;
&#xD;
          -  Allergy to atracurium and to any other drug used.&#xD;
&#xD;
          -  Patient under tutorship / curatorship&#xD;
&#xD;
          -  Not affiliated with social insurance&#xD;
&#xD;
          -  Patient with AME&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christophe BAILLARD</last_name>
    <phone>00 33 1 58 41 14 87</phone>
    <email>christophe.baillard@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie BENHAMMANI-GODARD</last_name>
    <phone>00 33 1 58 41 11 90</phone>
    <email>maraie.godard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Anesthésie Réanimation Chirurgicale Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe BAILLARD</last_name>
      <phone>00 33 1 58 41 14 87</phone>
      <email>christophe.baillard@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Debaene B, Beaussier M, Meistelman C, Donati F, Lienhart A. Monitoring the onset of neuromuscular block at the orbicularis oculi can predict good intubating conditions during atracurium-induced neuromuscular block. Anesth Analg. 1995 Feb;80(2):360-3.</citation>
    <PMID>7818124</PMID>
  </reference>
  <reference>
    <citation>Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J; 8th International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007 Aug;51(7):789-808.</citation>
    <PMID>17635389</PMID>
  </reference>
  <reference>
    <citation>Plaud B, Baillard C, Bourgain JL, Bouroche G, Desplanque L, Devys JM, Fletcher D, Fuchs-Buder T, Lebuffe G, Meistelman C, Motamed C, Raft J, Servin F, Sirieix D, Slim K, Velly L, Verdonk F, Debaene B. Guidelines on muscle relaxants and reversal in anaesthesia. Anaesth Crit Care Pain Med. 2020 Feb;39(1):125-142. doi: 10.1016/j.accpm.2020.01.005. Epub 2020 Jan 8.</citation>
    <PMID>31926308</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>March 25, 2021</last_update_submitted>
  <last_update_submitted_qc>March 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tracheal intubation</keyword>
  <keyword>Atracurium</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

